Through the entire pandemic stage, AstraZeneca offered the vaccine at no profit globally. That included a significant amount of donations that were made either through countries or directly on AstraZeneca's behalf. At the beginning of the year, as we moved into an endemic phase, we moved to tier pricing in countries that we have vaccine contracts with.
On April 25th, 2022. See this statement in context.